Overexpression ofMLH‐1andpsoriasingenes in cutaneous angiofibromas from tuberous sclerosis complex patients
- 6 September 2006
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 33 (9) , 608-613
- https://doi.org/10.1111/j.1600-0560.2006.00483.x
Abstract
Tuberous sclerosis complex (TSC) is associated with mutations in two likely tumor-suppressor genes (TSC1 and TSC2) and characterized by the development of tumor-like growths (angiofibromas) in a variety of tissues and organs, particularly brain and skin. Employing a DNA-microarray assay, able to detect mRNA production from 1176 different basic genes, we analyzed the gene-expression levels in a cutaneous hamartoma sample from a TSC patient. Altered gene expressions detected by microarray technology were further checked by quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) in the same material and in cutaneous hamartoma samples obtained from five other TSC patients. The results obtained by the microarray technology in one hamartoma specimen, confirmed by the RT-PCR results obtained in the same material and in five other hamartoma specimens, demonstrated that TSC-related angiofibromas exhibit significant mRNA overexpression of two genes, represented by MLH-1 and psoriasin. The overexpression of MLH-1, which codes for a DNA mismatch repair protein, and psoriasin, which codes for a specific chemoattractant factor for CD4+ T cells, implicated in the pathogenesis of inflammatory skin disease, and expressed in excess during abnormal pathways of cell growth, may shed light on the pathogenesis of the proliferative skin lesion.Keywords
This publication has 20 references indexed in Scilit:
- Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis ComplexEuropean Journal of Human Genetics, 2005
- Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complexActa Neurologica Scandinavica, 2004
- Tuberous sclerosis complex: genetics to pathogenesisPediatric Neurology, 2003
- Loss of DNA Mismatch Repair Proteins in Skin Tumors From Patients With Muir–Torre Syndrome and MSH2 or MLH1 Germline MutationsThe American Journal of Surgical Pathology, 2002
- High-Frequency Microsatellite Instability is Associated with Defective DNA Mismatch Repair in Human MelanomaJournal of Investigative Dermatology, 2002
- Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotypeProceedings of the National Academy of Sciences, 2001
- Functional analysis ofMLH1mutations linked to hereditary nonpolyposis colon cancerGenes, Chromosomes and Cancer, 2001
- Inactivation of DNA Mismatch Repair by Increased Expression of Yeast MLH1Molecular and Cellular Biology, 2001
- Psoriasin (S100A7) Expression and Invasive Breast CancerThe American Journal of Pathology, 1999
- Psoriasin (S100A7)The International Journal of Biochemistry & Cell Biology, 1998